Introduction
It is well known that macrophages contribute to the formation and development of atherosclerotic lesions. 1 We have reported that low grade inflammation is also involved in the pathogenesis of diabetic nephropathy in a series of studies in human diabetic patients and animal models of diabetic nephropathy. [2] [3] [4] [5] On the other hand, angiotensin II (Ang II) plays important roles in the pathogenesis of atherosclerosis 6 and chronic kidney diseases including diabetic nephropathy. Ang II acts on endothelial cells, vascular smooth muscle cells and immune cells resulting in acceleration of atherosclerosis at least partly through low grade inflammation. 7 Ang II stimulates vascular smooth muscle cells to produce monocyte chemoattractant protein (MCP)-1, one of the major chemokines for macrophage infiltration. 8 Macrophages, which accumulate in atherosclerotic lesions or cardiac tissues, also produce angiotensin-converting enzyme (ACE), renin and Ang II. 9, 10 Concerning the direct effect of Ang II on macrophages, it is reported that the reninangiotensin system, including angiotensin II type 1 (AT 1 ) and type 2 (AT 2 ) receptors, is activated during differentiation of monocytes to macrophages. 11 Yanagitani et al. 12 also reported that Ang II directly stimulated up-regulation of peroxide production in macrophages through AT 1 -receptors. On the other hand, Kato et al. 13 reported that treatment with an ACE inhibitor (ACE-I) and an angiotensin II type 1 receptor blocker (ARB) down-regulated MCP-1 and transforming growth factor (TGF)-β‚ expression in the kidney, resulting in amelioration of renal damage in experimental diabetic rats. Mezzano et al.
14 also reported that activation of the renin-angiotensin system including locally-generated Ang II promoted interstitial inflammation in diabetic nephropathy through up-regulation of MCP-1 and Regulated upon Activation, Normal T cell Expressed and Secreted (RANTES). This evidence suggests that the renin-angiotensin system and macrophages synergistically promote inflammation in atherosclerotic lesions and diabetic kidney.
In the present study, intended to clarify the direct effects of Ang II on macrophages, we evaluated the expression profiles of proinflammatory genes in cultured human monocytes/macrophages after stimulation with Ang II using DNA microarray followed by quantitative real-time reverse transcription (RT)-PCR.
Material and methods

Materials
THP-1 cells, a human monocytic leukaemia cell line, were obtained from Dainippon Co. (Osaka, Japan). RPMI 1640 medium and fetal bovine serum (FBS) were obtained from Invitrogen Corp 
Gene expression analysis by DNA microarrays
The 9,589 gene expression profiles in PMAtreated THP-1 cells were examined using UniSet Human I Bioarray chip (CodeLink TM system, Amersham Bioscience, USA) as described previously. 15 The CodeLink TM platform consists of a glass slide. In brief, double-strand cDNA was synthesised from 5 μg of total RNA using T7-(dT) 24 oligonucleotide primer. From the double-stranded cDNA complementary RNA (cRNA) was synthesised by an in vitro transcription reaction, together with biotin-labelled ribonucleotide. Then, the biotinlabelled cRNA was denatured and hybridised to slides of CodeLink array for 18 hours at 37°C. After hybridisation, slides were washed in TNT buffer at 42°C for 60 minutes and fluorescence-labelled nucleotide was added to generate storeptavidinCy5-labelled RNA. Slides were scanned using CodeLink 
Quantitative analysis by real-time RT-PCR
To evaluate gene expression of cytokines and chemokines in PMA-treated THP-1 cells stimulated by AII, quantitative real-time RT-PCR was performed using a Light Cycler and LightCycler-FastStart SYBR Green 1 (Roche Diagnostics, Tokyo, Japan). After the addition of primers (final concentration: 0.3 μM), MgCl 2 (4 mM) and template DNA to the master mix, the following real-time RT-PCR protocol was performed. For monocyte chemoattractant protein (MCP)-2 and tissue growth factor (TGF)-β3, 50 cycles of denaturation (95°C for 10 seconds), annealing (62°C for 10 seconds) and extension (72°C for 7 seconds) were performed, and for MCP1, TGF-β1 and 50 cycles of denaturation (95°C for 10 seconds), annealing (68ºC for 10 seconds) and extension (72°C for 16 seconds) were done. To determine the specificity of each primer set, melting curve analysis was performed after the completion of PCR amplification.
Accumulated levels of fluorescence were analysed by a fit-point method after the melting curve analysis. The mRNA level of cytokines and chemokines was normalised to a house-keeping gene (human GAPDH mRNA) in each sample calculating the relative expression ratio. For amplification of the cDNA, the following oligonucleotide primers were used: MCP-2, sense GAPDH, sense 5´-TGAACGGGAAGCTCACTGG-3´, antisense 5´-TCCACCACCCTGTTGCTGTA-3´. The primers for MCP-1, TGF-β3 and RANTES were purchased from Roche Diagnostics (Tokyo, Japan). Three samples were used in each group and each experiment was performed twice.
Statistical analysis
All data are expressed as the mean±SEM. Differences between groups were examined for statistical significance using one-way analysis of variance (ANOVA) followed by Scheffe's test. A p value less than 0.05 was considered to denote the presence of a statistically significant difference. RT-PCR was also performed semi-quantitatively by densitometry. Both AT 1 -/AT 2 -receptors expressed in THP-1 cells with or without PMA stimulation and AT 1 -receptors were more strongly expressed than AT 2 -receptors. Expression of AT 1 -/AT 2 -receptors seemed to be up-regulated through differentiation to macrophages by PMA stimulation, though differences were not statistically significant (figure 1b).
Results
Gene
Comparison of gene expression profiles in a macrophage stimulated by Ang II
Genes up-regulated (1.5-fold and more) by Ang II stimulation compared with control and downregulated (0.67-fold and less) by AIIA compared with Ang II were listed in table 1. In total, 19 genes were listed. In particular, MCP-2, an important chemokine, was up-regulated by Ang II (1.65-fold) and significantly down-regulated by AIIA (13.80-fold). TGF-β3, a cytokine, was also up-regulated by Ang II (1.76-fold) and downregulated by AIIA (2.68-fold).
Quantitative gene expression analysis of chemokines and cytokines
We focused on chemokines and cytokines including MCP-2 and TGF-β3, from the results of the DNA arrays, so quantitative real-time RT-PCR was performed to quantify the gene expression level of chemokines and cytokines in cultured macrophages. Expression of mRNA was normalised to levels of GAPDH mRNA in each sample calculating the relative expression ratio. Ang II stimulation up-regulated MCP-2 mRNA expression by 1.8-fold compared with control (p<0.01). AIIA reduced the increase of MCP-2 expression by 24.9% (p<0.05). The expression of MCP-2 mRNA was remarkably up-regulated by the treatment with AT 2 -receptor antagonist (p<0.005 vs. control and Ang II+AIIA, n.s. vs. AII) (figure 2b). Although MCP-1 mRNA expression was increased by AIIA stimulation and decreased by AIIA, there was no statistical significance (figure 2a). There was no significant difference between four groups in TGF-β1, TGF-β3 and RANTES ( figure 2 c,d , and e).
Melting curve analysis confirmed the specificity of the PCR products (data not shown). Values are expressed as mean±SEM.
Discussion
We found the 19 genes were up-regulated by Ang II and down-regulated by AIIA in cultured macrophages using DNA microarray studies. Quantitative analysis with real-time RT-PCR showed that mRNA expression of MCP-2 was significantly increased by Ang II stimulation and markedly reduced by AIIA. We found similar changes of the expression of MCP-1 without significant difference. 
C O P Y R I G H T J R A A S L I M I T E D R E P R O D U C T I O N P R O H I B I T E D
There was no significant difference in gene expression of TGF-β3, TGF-β1 and RANTES.
The induction of MCP-2 was blocked by AIIA but not with AT 2 -receptor antagonists suggesting that MCP-2 is up-regulated through AT 1 -receptors. It has been reported that Ang II stimulates vascular smooth muscle cells and mesangial cells to produce MCP-1.
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With respect to direct effects of Ang II on macrophages, Ang II was shown to stimulate peroxide production in macrophages through 
AT 1 -receptors. 12 However, to the best of our knowledge, there has been no report that has described the proinflammtaory cytokines or chemokines produced from macrophages stimulated by Ang II.
The signal transduction mechanisms of AT 1 -and AT 2 -receptors are controversial. 17, 18 In general, the actions of Ang II mediated through AT 1 -receptors are quite different from the actions through AT 2 -receptors. 19 Ang II inhibits cell proliferation and vasoconstriction and promotes cell differentiation and natriuresis via AT 2 -receptors, counterbalancing the effects of AT 1 -receptors in various organs such as the heart, the kidney and the blood vessels. [20] [21] [22] It is also reported that AT 2 -receptors mediate programmed cell death. 23 Interestingly, in the current results, AT 2 -receptor antagonists enhanced the effect of Ang II to produce MCP-2 in cultured macrophages. These results suggest that Ang II up-regulates MCP-2 expression in macrophages via AT 1 -receptors and that the signal via AT 2 -receptors has opposite functions to the AT 1 -receptor on MCP-2 expression.
On the other hand, it is reported that the same corresponding domains in both of the Ang II receptor subtypes are equally able to mediate agonist-induced receptor activation despite key amino acid dissimilarities, suggesting the possibility of a common activation mechanism for the two receptor subtypes. 24 Esteban et al. 25 also reported that dual blockade of AT 1 -and AT 2 -receptor was necessary for prevention of interstitial monocyte infiltration in the kidney through suppression of nuclear factor-kappa B (NF-κB) and that inhibition of AT 1 -receptor only was incompletely effective using unilateral ureteral obstruction (UUO) model mice. This report seemed to be inconsistent with our results that AT 2 -receptor blockade up-regulated MCP-2 expression in cultured macrophages, counterbalancing the effects of AT 1 -receptors. However, we might not be able to compare these results because the study conditions are quite different in the two studies.
MCP-2 is a member of the C-C chemokine subfamily, and it shares over 60% sequence homology with MCP-1 and MCP-3 and about 30% homology with macrophage inflammatory protein (MIP)-1β, RANTES and MIP-1β. 26, 27 It is reported that MCP-2 activates various inflammatory cells, such as monocytes/ macrophages, T lymphocytes, basophils and eosinophils through CCR1, CCR2b and CCR5. [27] [28] [29] [30] [31] [32] In the present study, MCP-2 expression was upregulated in macrophages stimulated by Ang II, which might recruit other macrophages to inflammatory lesions.
In summary, Ang II directly stimulated cultured macrophages to express MCP-2 through AT 1 -receptors. MCP-2 may promote sequential recruitment of macrophages to inflammatory tissues, resulting in the formation of a vicious circle of microinflammation. We conclude that vasculo-or renoprotective effects of ACE-Is and AIIAs may be mediated, at least partly, by antiinflammatory actions. 
